Drug Profile
Ethinylestradiol/levonorgestrel - Gynetics
Alternative Names: Levonorgestrel/ethinylestradiol - Gynetics; PrevenLatest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator Gynetics
- Developer Gynetics; Nonindustrial source; Takeda
- Class Alkylated estrogenic steroids; Contraceptives; Hormonal replacements; Norpregnanes; Norpregnatrienes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Pregnancy
Most Recent Events
- 05 Jul 2019 Chemical structure information added
- 08 Jan 2019 Shire has been acquired and merged into Takeda
- 18 Jan 2000 Roberts Pharmaceutical has been merged into Shire Pharmaceuticals Group